busulfan has been researched along with Anemia, Aplastic in 99 studies
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Graft-versus-host disease (GVHD) prophylaxis consisted of tacrolimus and methotrexate." | 5.19 | Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. ( Baker, KS; Burroughs, LM; Deeg, HJ; Delaney, C; Domm, J; Englund, JA; Flowers, ME; Giller, RH; Nemecek, ER; Rawlings, DJ; Shimamura, A; Skoda-Smith, S; Storb, R; Storer, BE; Talano, JA; Thakar, MS; Torgerson, TR; Woolfrey, AE, 2014) |
| " To prevent from graft-versus-host disease (GVHD), cyclosporin A and short term methotrexate (MTX) were used." | 3.80 | [The outcome of thirteen patients with nonmalignant hematologic diseases treated with HLA haploidentical stem cell transplantation]. ( Chen, T; Du, Q; Huang, Y; Lin, X; Lu, Z; Song, C; Sun, C; Tao, Y; Tu, S; Wu, B, 2014) |
| "Secondary myelodysplastic syndrome and acute myelogenous leukemia (sMDS/sAML) are the most serious secondary events occurring after immunosuppressive therapy in patients with aplastic anemia." | 2.79 | Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. ( Baumann, I; Führer, M; Furlan, I; Göhring, G; Niemeyer, CM; Nöllke, P; Schlegelberger, B; Schwarz, S; Strahm, B; Teigler-Schlegel, A; Walther, JU; Yoshimi, A, 2014) |
| "Busulfan was added at the dose of 4 mg/kg to 200 mg/kg cyclophosphamide in 81 patients (3-53 years, median 24) with aplastic anemia to reduce graft rejection." | 2.71 | Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection. ( Aranha, FJ; Bacigalupo, A; Chamone, DA; Da Silva, RL; De Souza, CA; Dulley, FL; Macedo, MC; Mehta, J; Ruiz, MA; Saboya, R; Sturaro, D; Vigorito, AC, 2004) |
| "Stem cell transplants are often used to treat severe aplastic anemia or, alternatively, may be part of the treatment for an underlying malignant disease or a genetic disease." | 2.42 | Hematopoietic stem cells. ( Trigg, ME, 2004) |
| "Aplastic anemia is the bone marrow failure condition characterized by the development of hypocellularity in both marrow and peripheral blood compartments." | 1.51 | Genomic insult oriented mitochondrial instability and proliferative hindrance in the bone marrow of aplastic mice including stem/progenitor population. ( Chatterjee, R; Law, S, 2019) |
| "To investigate the efficacy and safety of haploidentical allo-HSCT in combination of reduced intensity preconditioning combined with cyclophosphamid (CTX)-induced immune tolerance after transplanitation for treatment of severe aplastic anemia (SAA)." | 1.43 | [Clinical Efficacy of Haploidentical Allo-HSCT of Reduced Intensity Preconditioning Combined with Induced Immune Tolerance after Transplantation for Severe Aplastic Anemia]. ( Chen, HR; Chen, P; Guo, Z; He, XP; Liu, XD; Lou, JX; Yang, K; Zhang, Y, 2016) |
| "To establish a novel severe aplastic anemia (SAA) mouse model by interferon-γ (IFN-γ) plus busulphan." | 1.37 | [A novel severe aplastic anemia mouse model induced by IFN-γ plus busulphan]. ( Chen, XF; Lin, ZH; Liu, H; Liu, HY; Ning, FY; Sun, F; Wang, H, 2011) |
| "In our experimental set up, we induced aplastic anemia by injecting busulfan and cyclophosphamide and leukemia by N-N' ethylnitrosourea intraperitoneally in inbred swiss albino mice." | 1.35 | Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation. ( Basak, P; Chaklader, M; Chatterjee, S; Chaudhuri, S; Das, M; Das, P; Dutta, RK; Law, S; Pereira, JA, 2009) |
| " Mice (n = 64/65) were dosed 10 times with BU at 0 (vehicle control), 8." | 1.33 | Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse. ( Andrews, CM; Gibson, FM; Gordon-Smith, EC; Molyneux, G; Pilling, AM; Rizzo, S; Sones, WR; Turton, JA; Williams, TC, 2006) |
| "5-FU combined with busulfan could impair the hematopoietic stem cells and resulted in an irreversible aplastic anemia in rats, making a rat aplastic anemia model with hematopoietic stem cell failure." | 1.31 | [A novel rat aplastic anemia model induced by 5-fluorouracil combined with busulfan]. ( Chu, J; Ding, S; Liu, A; Wang, S; Xu, S; Zhao, J, 2001) |
| "Busulfan was given again for 40 days (a total of 80 mg) in another hospital when the platelet count increased to 71." | 1.30 | [Complete remission of essential thrombocythemia after recovery from severe bone marrow aplasia induced by busulfan treatment]. ( Hamaguchi, H; Nagata, K; Yamamoto, K, 1997) |
| "Dyskeratosis congenita is recognized by its dermal lesions and constitutional aplastic anemia in some cases." | 1.30 | Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. ( Alimoghadam, K; Ghahremani, G; Ghavamzadeh, A; Jahani, M; Khodabandeh, A; Nasseri, P, 1999) |
| "Data on 181 of 230 patients with aplastic anemia, leukemias, and lymphomas who had BMT before puberty (mean age, 9." | 1.30 | Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. ( Bakker, B; Cahn, JY; Cohen, A; Dopfer, R; Esperou, H; Gaiero, A; Kolb, HJ; Leiper, AD; Merlo, F; Rovelli, A; Socié, G; Uderzo, C; van Lint, MT, 1999) |
| "Using YSSXT to treat aplastic anemia that the effectiveness might be realized through promoting the proliferation of hematopoietic stem cells of bone marrow, enhancing the non-specific immunity, and the anti-infection as well as body resistance." | 1.30 | [Experimental study on effect of yishen shengxue tablet in treating aplastic anemia]. ( Wang, T; Yang, J; Zhou, A, 1999) |
| "Twenty-three patients developed a malignancy 1." | 1.29 | Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. ( Deeg, HJ; Devergie, A; Gluckman, E; Henry-Amar, M; Schoch, G; Socié, G; Storb, R; Sullivan, KM; Witherspoon, RP, 1996) |
| "A case of chronic myelogenous leukemia (CML) of 10-year survival in described." | 1.28 | [Bone marrow aplasia without blast crisis in a case of CML of 10-year survival]. ( Abe, R; Ishibashi, T; Kariyone, S; Kimura, H; Matsuda, S; Shichishima, T; Shiga, Y; Uchida, T; Yokoyama, A; Yui, T, 1989) |
| " High dose animals had greater initial responses than low dosed dogs but long term responses were not significantly different." | 1.26 | Autologous bone marrow infusion following high dose chemotherapy of the canine transmissible venereal tumor (TVT). ( Epstein, RB; Sarpel, SC, 1980) |
| "Albuterol at a lower dose (0." | 1.26 | beta 2-Adrenergic stimulation of erythropoiesis in busulfan treated mice. ( Bauer, C; Jelkmann, W, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 52 (52.53) | 18.7374 |
| 1990's | 10 (10.10) | 18.2507 |
| 2000's | 17 (17.17) | 29.6817 |
| 2010's | 17 (17.17) | 24.3611 |
| 2020's | 3 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Kerbauy, MN | 1 |
| Mariano, L | 1 |
| Seber, A | 1 |
| Rocha, V | 1 |
| Yu, ZP | 1 |
| Ding, JH | 1 |
| Sun, AN | 1 |
| Chen, BA | 1 |
| Ge, Z | 1 |
| Wu, DP | 1 |
| Jia, W | 1 |
| Zhen, M | 1 |
| Li, L | 1 |
| Zhou, C | 1 |
| Sun, Z | 1 |
| Liu, S | 2 |
| Zhao, Z | 1 |
| Li, J | 2 |
| Wang, C | 1 |
| Bai, C | 1 |
| Qin, X | 1 |
| Zhu, YP | 1 |
| Luo, CJ | 1 |
| Zhou, M | 1 |
| Huang, K | 1 |
| Chen, C | 2 |
| Zhang, WP | 1 |
| Sun, Y | 1 |
| Luo, RM | 1 |
| Tang, XF | 1 |
| Yang, T | 1 |
| Song, XM | 1 |
| Hu, SY | 1 |
| Sun, ZM | 1 |
| Hu, J | 1 |
| Wang, SQ | 1 |
| Chen, J | 2 |
| Chatterjee, R | 3 |
| Law, S | 4 |
| Xu, LP | 2 |
| Xu, ZL | 1 |
| Wang, FR | 2 |
| Mo, XD | 2 |
| Han, TT | 2 |
| Han, W | 2 |
| Chen, YH | 2 |
| Zhang, YY | 2 |
| Wang, JZ | 2 |
| Wang, Y | 1 |
| Yan, CH | 2 |
| Sun, YQ | 2 |
| Tang, FF | 1 |
| Zhang, XH | 2 |
| Huang, XJ | 2 |
| Chen, QH | 1 |
| Wang, J | 1 |
| Lin, SF | 1 |
| Xue, HM | 1 |
| Yoshimi, A | 1 |
| Strahm, B | 1 |
| Baumann, I | 1 |
| Furlan, I | 1 |
| Schwarz, S | 1 |
| Teigler-Schlegel, A | 1 |
| Walther, JU | 1 |
| Schlegelberger, B | 1 |
| Göhring, G | 1 |
| Nöllke, P | 1 |
| Führer, M | 1 |
| Niemeyer, CM | 1 |
| Wang, Z | 1 |
| Zheng, X | 1 |
| Yan, H | 1 |
| Li, D | 1 |
| Wang, H | 2 |
| Tao, Y | 1 |
| Wu, B | 1 |
| Du, Q | 1 |
| Sun, C | 2 |
| Lin, X | 1 |
| Huang, Y | 1 |
| Tu, S | 1 |
| Song, C | 1 |
| Lu, Z | 1 |
| Chen, T | 1 |
| Burroughs, LM | 1 |
| Nemecek, ER | 1 |
| Torgerson, TR | 1 |
| Storer, BE | 1 |
| Talano, JA | 1 |
| Domm, J | 1 |
| Giller, RH | 1 |
| Shimamura, A | 1 |
| Delaney, C | 1 |
| Skoda-Smith, S | 1 |
| Thakar, MS | 1 |
| Baker, KS | 1 |
| Rawlings, DJ | 1 |
| Englund, JA | 1 |
| Flowers, ME | 1 |
| Deeg, HJ | 2 |
| Storb, R | 3 |
| Woolfrey, AE | 1 |
| Chen, YF | 1 |
| Zhao, ZQ | 1 |
| Wu, ZM | 1 |
| Zou, ZY | 1 |
| Luo, XJ | 1 |
| Xie, C | 1 |
| Liang, Y | 1 |
| Chen, F | 1 |
| Wu, D | 1 |
| Tang, X | 1 |
| Miao, M | 1 |
| Fu, C | 1 |
| Qiu, H | 1 |
| Jin, Z | 1 |
| Xue, S | 1 |
| Ma, X | 1 |
| Sun, A | 1 |
| Chang, W | 1 |
| Ruan, C | 1 |
| Chattopadhyay, S | 1 |
| Zuo, SN | 1 |
| Guo, Z | 1 |
| Chen, HR | 1 |
| Liu, XD | 1 |
| Yang, K | 1 |
| Lou, JX | 1 |
| Zhang, Y | 1 |
| Chen, P | 1 |
| He, XP | 1 |
| Kerbauy, FR | 1 |
| Tirapelli, B | 1 |
| Akabane, H | 1 |
| Oliveira, JS | 2 |
| Ommati, LV | 1 |
| Rodrigues, CA | 1 |
| Silva, AR | 1 |
| Silva, LP | 1 |
| Chaufaille, ML | 1 |
| Ruiz-Delgado, GJ | 1 |
| Gutiérrez-Riveroll, KI | 1 |
| Gutiérrez-Aguirre, CH | 2 |
| Gómez-Almaguer, D | 2 |
| Eyzaguirre-Zapata, R | 1 |
| Priesca-Marin, M | 1 |
| González-Carrillo, ML | 1 |
| Ruiz-Argüelles, GJ | 2 |
| Chatterjee, S | 1 |
| Basak, P | 1 |
| Das, M | 1 |
| Das, P | 1 |
| Pereira, JA | 1 |
| Dutta, RK | 1 |
| Chaklader, M | 1 |
| Chaudhuri, S | 1 |
| Garming-Legert, K | 1 |
| Remberger, M | 1 |
| Ringdén, O | 2 |
| Hassan, M | 2 |
| Dahllöf, G | 1 |
| Mori, T | 1 |
| Ning, FY | 1 |
| Lin, ZH | 1 |
| Liu, H | 1 |
| Chen, XF | 1 |
| Sun, F | 1 |
| Liu, HY | 1 |
| Murotani, Y | 1 |
| Kuroda, J | 1 |
| Kimura, S | 1 |
| Terao, K | 1 |
| Fukiya, E | 1 |
| Ozawa, M | 1 |
| Kobayashi, Y | 1 |
| Yoshikawa, T | 1 |
| Gibson, FM | 2 |
| Andrews, CM | 2 |
| Diamanti, P | 1 |
| Rizzo, S | 2 |
| Macharia, G | 1 |
| Gordon-Smith, EC | 2 |
| Williams, T | 1 |
| Turton, J | 1 |
| Chu, JX | 1 |
| Zhao, JM | 1 |
| Ding, SL | 1 |
| Xu, SC | 1 |
| Liu, AR | 1 |
| Wang, SP | 1 |
| HAYHOE, FG | 1 |
| KOK, D | 1 |
| VAN ESSER, JG | 1 |
| KHURGIN, MI | 1 |
| KHASANOVA, RI | 1 |
| LANGERON, L | 1 |
| CROCCEL, L | 1 |
| ROUTIER, G | 1 |
| BOYAVAL, M | 1 |
| AUBERTIN, E | 1 |
| DAVID-CHAUSSE, F | 1 |
| ROY, A | 1 |
| FENELON, J | 1 |
| FRICK, PG | 1 |
| WAGNER, K | 1 |
| STERZ, H | 1 |
| ANTIC, M | 1 |
| RADOJEVIC, B | 1 |
| POGOSIAN, AS | 1 |
| MAISIN, J | 1 |
| DUNJIC, A | 1 |
| GALLINELLI, R | 1 |
| BARBIERI, U | 1 |
| PLAUCHU, M | 1 |
| DALMAIS, J | 1 |
| GUINGAND, M | 1 |
| GRUENWALD, H | 1 |
| TAUB, RN | 1 |
| WONG, FM | 1 |
| KIOSSOBLOU, KA | 1 |
| DAMESHEK, W | 1 |
| LIVSHITS, RA | 1 |
| Dulley, FL | 1 |
| Vigorito, AC | 1 |
| Aranha, FJ | 1 |
| Sturaro, D | 1 |
| Ruiz, MA | 1 |
| Saboya, R | 1 |
| Macedo, MC | 1 |
| Da Silva, RL | 1 |
| Chamone, DA | 1 |
| Mehta, J | 1 |
| Bacigalupo, A | 1 |
| De Souza, CA | 1 |
| Asano, Y | 1 |
| Kanda, Y | 1 |
| Ogawa, N | 1 |
| Sakata-Yanagimoto, M | 1 |
| Nakagawa, M | 1 |
| Kawazu, M | 1 |
| Goyama, S | 1 |
| Kandabashi, K | 1 |
| Izutsu, K | 1 |
| Imai, Y | 1 |
| Hangaishi, A | 1 |
| Kurokawa, M | 1 |
| Tsujino, S | 1 |
| Ogawa, S | 1 |
| Aoki, K | 1 |
| Chiba, S | 1 |
| Motokura, T | 1 |
| Hirai, H | 1 |
| Trigg, ME | 1 |
| Spyridonidis, A | 1 |
| Küttler, T | 1 |
| Wäsch, R | 1 |
| Samek, E | 1 |
| Waterhouse, M | 1 |
| Behringer, D | 1 |
| Bertz, H | 1 |
| Finke, J | 1 |
| Turton, JA | 1 |
| Sones, WR | 1 |
| Pilling, AM | 1 |
| Williams, TC | 1 |
| Molyneux, G | 1 |
| Vela-Ojeda, J | 1 |
| Jaime-Pérez, JC | 1 |
| Cantú-Rodríguez, OG | 1 |
| Sobrevilla-Calvo, P | 1 |
| Rivas-Vera, S | 1 |
| Gómez-Rangel, JD | 1 |
| Giebel, S | 1 |
| Wojnar, J | 1 |
| Krawczyk-Kulis, M | 1 |
| Markiewicz, M | 1 |
| Wylezoł, I | 1 |
| Seweryn, M | 1 |
| Holowiecka-Goral, A | 1 |
| Holowiecki, J | 1 |
| Beschorner, WE | 1 |
| Pino, J | 1 |
| Boitnott, JK | 1 |
| Tutschka, PJ | 2 |
| Santos, GW | 2 |
| O'Reilly, RJ | 1 |
| Trainor, KJ | 2 |
| Morley, AA | 4 |
| Seshadri, RS | 2 |
| Larrain, C | 1 |
| Cruz, A | 1 |
| Codoceo, V | 1 |
| Ideriha, NM | 1 |
| Vugman, I | 1 |
| Falcão, RP | 1 |
| Thomas, ED | 2 |
| Haak, HL | 2 |
| Epstein, RB | 1 |
| Sarpel, SC | 1 |
| den Ottolander, GJ | 1 |
| te Velde, J | 1 |
| Veenhof, W | 1 |
| Kleiverda, K | 1 |
| Spaander, PJ | 1 |
| Jelkmann, W | 1 |
| Bauer, C | 1 |
| Fitchen, JH | 1 |
| Cline, MJ | 1 |
| Yamagishi, M | 1 |
| Niki, T | 1 |
| Hiraoka, A | 1 |
| Dohmae, N | 1 |
| Uchino, H | 1 |
| Gale, RJ | 1 |
| Ljungman, P | 1 |
| Békássy, AN | 1 |
| Oberg, G | 1 |
| Ghavamzadeh, A | 2 |
| Jahani, M | 2 |
| Baybordi, E | 1 |
| Socié, G | 2 |
| Schoch, G | 1 |
| Henry-Amar, M | 1 |
| Witherspoon, RP | 1 |
| Devergie, A | 1 |
| Sullivan, KM | 1 |
| Gluckman, E | 1 |
| van Tol, MJ | 1 |
| Gerritsen, EJ | 1 |
| de Lange, GG | 1 |
| van Leeuwen, AM | 1 |
| Jol-van der Zijde, CM | 1 |
| Oudeman-Gruber, NJ | 1 |
| de Vries, E | 1 |
| Radl, J | 1 |
| Vossen, JM | 1 |
| Yamamoto, K | 1 |
| Nagata, K | 1 |
| Hamaguchi, H | 1 |
| Al-Fiar, FZ | 1 |
| Colwill, R | 1 |
| Lipton, JH | 1 |
| Fyles, G | 1 |
| Spaner, D | 1 |
| Messner, H | 1 |
| Alimoghadam, K | 1 |
| Nasseri, P | 1 |
| Khodabandeh, A | 1 |
| Ghahremani, G | 1 |
| Cohen, A | 1 |
| Rovelli, A | 1 |
| Bakker, B | 1 |
| Uderzo, C | 1 |
| van Lint, MT | 1 |
| Esperou, H | 1 |
| Gaiero, A | 1 |
| Leiper, AD | 1 |
| Dopfer, R | 1 |
| Cahn, JY | 1 |
| Merlo, F | 1 |
| Kolb, HJ | 2 |
| Zhou, A | 1 |
| Wang, T | 1 |
| Yang, J | 1 |
| Zhao, J | 1 |
| Chu, J | 1 |
| Ding, S | 1 |
| Xu, S | 1 |
| Liu, A | 1 |
| Wang, S | 1 |
| Bright, R | 1 |
| Eisendrath, S | 1 |
| Damon, L | 1 |
| Pugsley, CA | 1 |
| Forbes, IJ | 1 |
| Morley, A | 3 |
| Trainor, K | 1 |
| Remes, J | 1 |
| Copelan, EA | 1 |
| Wiktor-Jedrzejczak, W | 1 |
| Szczylik, C | 1 |
| Matej, H | 1 |
| Pojda, Z | 1 |
| Ratajczak, MZ | 1 |
| Myc, A | 1 |
| Siekierzyński, M | 1 |
| Kansy, J | 1 |
| Kłos, M | 1 |
| Rybicki, Z | 1 |
| Shiga, Y | 1 |
| Yokoyama, A | 1 |
| Ishibashi, T | 1 |
| Shichishima, T | 1 |
| Abe, R | 1 |
| Yui, T | 1 |
| Kimura, H | 1 |
| Matsuda, S | 1 |
| Uchida, T | 1 |
| Kariyone, S | 1 |
| Atkinson, K | 1 |
| Biggs, J | 1 |
| Noble, G | 1 |
| Ashby, M | 1 |
| Concannon, A | 1 |
| Dodds, A | 1 |
| Furuse, N | 1 |
| Hayasaka, S | 1 |
| Yamamoto, Y | 1 |
| Setogawa, T | 1 |
| Inoue, S | 1 |
| Fickers, M | 1 |
| Speck, B | 1 |
| Blake, J | 2 |
| Weiden, PL | 1 |
| Ochs, HD | 1 |
| Kolb, H | 1 |
| Graham, TC | 1 |
| Floersheim, GL | 1 |
| Palva, IP | 1 |
| Wasastjerna, C | 1 |
| Dyk, T | 1 |
| Piotrowski, M | 1 |
| Kostecka, W | 1 |
| Schmidt, M | 1 |
| Havemann, K | 1 |
| Udupa, KB | 2 |
| Okamura, H | 1 |
| Reissmann, KR | 2 |
| Kawada, K | 1 |
| Ernst, P | 1 |
| Boye Nielsen, J | 1 |
| Killman, SE | 1 |
| Olmer, J | 1 |
| Muratore, R | 1 |
| Gabriel, B | 1 |
| Canu, AM | 1 |
| Klimova, NF | 1 |
| Cherntsova, TA | 1 |
| Protasova, TG | 1 |
| Demmler, K | 1 |
| Burkhardt, R | 1 |
| Prechtel, K | 1 |
| Albrecht, M | 1 |
| Tackmann, W | 1 |
| Pribilla, W | 1 |
| Torre-Lopez, E | 1 |
| Sanchez-Medal, L | 1 |
| Hunstein, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I/II Feasibility Study of Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) Using a Self-Inactivating Lentiviral Vector (AProArt) to Transduce Autologous CD34 Hematopoietic Cells[NCT03538899] | Phase 1/Phase 2 | 25 participants (Anticipated) | Interventional | 2018-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for busulfan and Anemia, Aplastic
| Article | Year |
|---|---|
Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
Topics: Adenoviridae Infections; Adenoviruses, Human; Adolescent; Adult; Aged; Anemia, Aplastic; BK Virus; B | 2003 |
Hematopoietic stem cells.
Topics: Anemia, Aplastic; Antineoplastic Agents; Busulfan; Child; Fetal Blood; Hematopoietic Stem Cell Trans | 2004 |
Animal models for acquired bone marrow failure syndromes.
Topics: Anemia, Aplastic; Animals; Benzene; Bone Marrow Diseases; Busulfan; Chloramphenicol; Disease Models, | 2005 |
Allogenic bone marrow transplantation: current status and future directions.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Cell Separation; Cyclophosphamide; Erythroc | 1983 |
Experimental drug-induced aplastic anaemia.
Topics: Anemia, Aplastic; Animals; Benzene; Busulfan; Chloramphenicol; Colony-Forming Units Assay; Disease M | 1980 |
Conditioning regimens for allogeneic bone marrow transplantation.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; | 1992 |
[Bone marrow transplantation in pediatric patients: review of progress].
Topics: Anemia, Aplastic; Blast Crisis; Bone Marrow Transplantation; Busulfan; Child; Cyclosporins; Graft vs | 1987 |
5 trials available for busulfan and Anemia, Aplastic
| Article | Year |
|---|---|
Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; | 2014 |
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents, Alkylating; Busulf | 2014 |
Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia.
Topics: Adolescent; Allografts; Anemia, Aplastic; Busulfan; Child; Child, Preschool; Cyclophosphamide; Disea | 2017 |
The effect of administration order of BU and CY on toxicity in hematopoietic SCT in humans.
Topics: Adolescent; Adult; Anemia, Aplastic; Busulfan; Cohort Studies; Cyclophosphamide; Follow-Up Studies; | 2009 |
Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Cause of Death; Child; C | 2004 |
87 other studies available for busulfan and Anemia, Aplastic
| Article | Year |
|---|---|
The impact of low dose busulfan on gonodal function after allogeneic hematopoietic stem cell transplantation for aplastic anemia.
Topics: Anemia, Aplastic; Busulfan; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; | 2020 |
A New Conditioning Regimen Can Significantly Promote Post-Transplant Immune Reconstitution and Improve the Outcome of Umbilical Cord Blood Transplantation for Patients.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Busul | 2019 |
Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs.
Topics: Anemia, Aplastic; Animals; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Busulfan; Cell Diff | 2020 |
Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
Topics: Adolescent; Adult; Anemia, Aplastic; Busulfan; Child; Child, Preschool; Female; Histocompatibility; | 2021 |
Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia.
Topics: Anemia, Aplastic; Animals; Apoptosis; Bone Marrow; Busulfan; Chemokine CXCL12; Cyclophosphamide; Dis | 2018 |
Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Female; Hematopoietic Ste | 2018 |
[Relationship of Blimp-1 Hypoexpression with Pathogenesis of Aplastic Anemia].
Topics: Anemia, Aplastic; Animals; Busulfan; Disease Models, Animal; Mice; Positive Regulatory Domain I-Bind | 2018 |
Genomic insult oriented mitochondrial instability and proliferative hindrance in the bone marrow of aplastic mice including stem/progenitor population.
Topics: Anemia, Aplastic; Animals; Apoptosis; Busulfan; Cell Proliferation; Cellular Senescence; Disease Mod | 2019 |
Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Busulfan; Child; Child, Preschool; Cohort Studies; Cord Blood Stem Cel | 2014 |
[The outcome of thirteen patients with nonmalignant hematologic diseases treated with HLA haploidentical stem cell transplantation].
Topics: Anemia, Aplastic; Busulfan; Graft vs Host Disease; Hematologic Diseases; Histocompatibility; HLA Ant | 2014 |
The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice.
Topics: Anemia, Aplastic; Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Busulfan; Cyclophos | 2014 |
[Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survi | 2015 |
Deregulation of vital mitotic kinase-phosphatase signaling in hematopoietic stem/progenitor compartment leads to cellular catastrophe in experimental aplastic anemia.
Topics: Anemia, Aplastic; Animals; Busulfan; Cell Cycle Proteins; Cyclophosphamide; Female; Hematopoietic St | 2016 |
[Clinical Efficacy of Haploidentical Allo-HSCT of Reduced Intensity Preconditioning Combined with Induced Immune Tolerance after Transplantation for Severe Aplastic Anemia].
Topics: Anemia, Aplastic; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Fathers; Hematopo | 2016 |
A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Drug Therapy, | 2009 |
A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting.
Topics: Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Blood Don | 2009 |
Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation.
Topics: Anemia, Aplastic; Animals; Antigens, Ly; Bone Marrow Cells; Busulfan; Cell Cycle; Cell Proliferation | 2009 |
Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI.
Topics: Adolescent; Age Factors; Anemia, Aplastic; Area Under Curve; Busulfan; Cyclophosphamide; Dose Fracti | 2011 |
[Conditioning regimen of allogeneic hematopoietic stem cell transplantation for aplastic anemia in Japan].
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Female; | 2011 |
[A novel severe aplastic anemia mouse model induced by IFN-γ plus busulphan].
Topics: Anemia, Aplastic; Animals; Busulfan; Disease Models, Animal; Female; Interferon-gamma; Mice; Mice, I | 2011 |
Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Female; Fractures, Bone; Graft Rejection; G | 2002 |
A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse.
Topics: Anemia, Aplastic; Animals; Bone Marrow Cells; Busulfan; Female; Immunosuppressive Agents; Mice; Mice | 2003 |
[Activation of auto-mesenchymal stem cells of skeletal muscle by bone morphogenetic protein for rescuing bone marrow failure].
Topics: Anemia, Aplastic; Animals; Bone Morphogenetic Proteins; Busulfan; Cell Differentiation; Female; Fluo | 2002 |
Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.
Topics: Anemia; Anemia, Aplastic; Busulfan; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positi | 1957 |
[Aplastic anemia following myleran treatment of chronic myeloid leukemia].
Topics: Anemia; Anemia, Aplastic; Busulfan; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positi | 1958 |
[Bone marrow aplasia consecutive to myleran therapy of chronic myeloid leukemia].
Topics: Anemia, Aplastic; Bone Marrow; Busulfan; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL P | 1959 |
[Chronic myeloid leukosis treated with 1-4-dimethane sulfonyl oxybutane; secondary pancytopenia].
Topics: Anemia; Anemia, Aplastic; Busulfan; Humans; Leukemia; Leukemia, Myeloid; Pancytopenia; Tracheophyta | 1959 |
[Apropos of 2 cases of pancytopenia in the course of the treatment with misulban].
Topics: Anemia; Anemia, Aplastic; Busulfan; Humans; Pancytopenia; Tracheophyta | 1960 |
[Fatal pancytopenia after treatment of polycythemia vera with myleran].
Topics: Anemia; Anemia, Aplastic; Busulfan; Humans; Pancytopenia; Polycythemia Vera; Tracheophyta | 1960 |
[Fatal pancytopenia caused by sulfabutin].
Topics: Anemia; Anemia, Aplastic; Busulfan; Humans; Pancytopenia; Tracheophyta | 1961 |
[Bone marrow aplasia in therapy of chronic myelosis with myleran].
Topics: Anemia, Aplastic; Bone Marrow; Busulfan; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; | 1961 |
[Aplasia of the bone marrow in patients with chronic myelocytic leukemia treated with myelosan].
Topics: Anemia; Anemia, Aplastic; Bone Marrow; Busulfan; Humans; Leukemia; Leukemia, Myelogenous, Chronic, B | 1962 |
[THE POSSIBLE ROLE OF THE THYMUS AND OF LYMPHOID TISSUE IN SECONDARY DISEASE IN THE RAT].
Topics: Anemia; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Lymphoid Tissue; Pharmacology; Phys | 1963 |
[OBSERVATIONS ON A CASE OF CHRONIC MYELOID LEUKOSIS MASKED BY TREATMENT WITH 1-4-DIMETHANESULFONOXYBUTANE].
Topics: Anemia; Anemia, Aplastic; Busulfan; Gastrointestinal Hemorrhage; Leukemia; Leukemia, Myeloid; Toxico | 1963 |
[MEDULLARY APLASIA DURING THE USE OF 4 ANTIMITOTICS: CARYOLYSIN, MYLERAN, THIOTEPA, ENDOXAN (APROPOS OF 32 CASES)].
Topics: Anemia; Anemia, Aplastic; Antimitotic Agents; Busulfan; Cyclophosphamide; Neoplasms; Nitrogen Mustar | 1963 |
PHYTOHAEMAGGLUTININ IN TREATMENT OF APLASTIC ANAEMIA.
Topics: Anemia; Anemia, Aplastic; Busulfan; Injections; Injections, Intravenous; Phenacetin; Phytohemaggluti | 1965 |
[On cytopenia in a female patient with chronic myeloid leukemia following myelosan therapy].
Topics: Anemia; Anemia, Aplastic; Busulfan; Female; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-AB | 1962 |
Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin.
Topics: Adult; Aged; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Bo | 2005 |
Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.
Topics: Anemia, Aplastic; Animals; Apoptosis; Blood Cell Count; Bone Marrow Cells; Busulfan; Dose-Response R | 2006 |
Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cycl | 2006 |
Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Disease-Free | 2006 |
Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Carmustine; Cytomegalovirus Infections; Gra | 1980 |
A proliferative defect of marrow cells in experimental chronic hypoplastic marrow failure (aplastic anaemia).
Topics: Anemia, Aplastic; Animals; Bone Marrow; Busulfan; Cell Division; Cells, Cultured; Colony-Forming Uni | 1980 |
[Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
Topics: Adult; Aged; Anemia, Aplastic; Busulfan; Female; Humans; Leukemia, Myeloid; Leukocyte Count; Male; M | 1984 |
Ectopic bone marrow development in experimental busulfan-induced hypoplastic anemia in mice.
Topics: Anemia, Aplastic; Animals; Blood Cell Count; Bone Development; Bone Marrow; Bone Marrow Diseases; Bo | 1984 |
Allogeneic bone marrow transplantation for blood cell disorders.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Animals; Bone Marrow Transplantation; Busulfan; | 1982 |
Autologous bone marrow infusion following high dose chemotherapy of the canine transmissible venereal tumor (TVT).
Topics: Anemia, Aplastic; Animals; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Dogs; Dose-Respo | 1980 |
Busulphan aplasia in rabbits: a model for human aplastic anaemia.
Topics: Anemia, Aplastic; Animals; Bone Marrow; Busulfan; Disease Models, Animal; Erythrocyte Indices; Hemat | 1982 |
beta 2-Adrenergic stimulation of erythropoiesis in busulfan treated mice.
Topics: Albuterol; Anemia, Aplastic; Animals; Busulfan; Erythrocyte Indices; Erythrocytes; Erythropoiesis; E | 1980 |
The effect of granulopoietic stress in mice with "latent" bone marrow failure.
Topics: Anemia, Aplastic; Animals; Bone Marrow Cells; Busulfan; Colony-Forming Units Assay; Female; Glucans; | 1980 |
[On an animal model of aplastic anemia induced by busulfan (author's transl)].
Topics: Anemia, Aplastic; Animals; Busulfan; Disease Models, Animal; Female; Male; Mice | 1980 |
The mononuclear phagocyte system in experimental chronic marrow failure.
Topics: Anemia, Aplastic; Animals; Blood Bactericidal Activity; Bone Marrow Cells; Busulfan; Carbon; Cell Co | 1980 |
Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.
Topics: Adolescent; Adult; Alopecia; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Child; Child, | 1995 |
Bone marrow transplantation in Iran.
Topics: Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; | 1994 |
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Child; Child, Pres | 1996 |
The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation.
Topics: Anemia, Aplastic; B-Lymphocytes; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cell Survival; | 1996 |
[Complete remission of essential thrombocythemia after recovery from severe bone marrow aplasia induced by busulfan treatment].
Topics: Anemia, Aplastic; Busulfan; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Humans; M | 1997 |
Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Dise | 1997 |
Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cycloph | 1999 |
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.
Topics: Adolescent; Adult; Age Factors; Anemia, Aplastic; Body Height; Bone Marrow Transplantation; Busulfan | 1999 |
[Experimental study on effect of yishen shengxue tablet in treating aplastic anemia].
Topics: Adjuvants, Immunologic; Anemia, Aplastic; Animals; Anti-Infective Agents; Busulfan; Drugs, Chinese H | 1999 |
[A novel rat aplastic anemia model induced by 5-fluorouracil combined with busulfan].
Topics: Anemia, Aplastic; Animals; Blood Cell Count; Busulfan; Disease Models, Animal; Female; Fluorouracil; | 2001 |
A case of factitious aplastic anemia.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents, Alkylating; Busulfan; Cyclospo | 2001 |
Immunologic abnormalities in an animal model of chronic hypoplastic marrow failure induced by busulfan.
Topics: Anemia, Aplastic; Animals; Antibody-Producing Cells; B-Lymphocytes; Blood Cell Count; Busulfan; Chro | 1978 |
Chronic hypoplastic marrow failure and residual injury.
Topics: Anemia, Aplastic; Animals; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cell Division; Chroni | 1978 |
Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol.
Topics: Anemia, Aplastic; Animals; Bone Marrow; Bone Marrow Cells; Busulfan; Cell Count; Chloramphenicol; Di | 1976 |
Allogeneic bone marrow transplantation from HLA-identical siblings following conditioning with busulfan and cyclophosphamide. First results.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; | 1989 |
[Bone marrow aplasia without blast crisis in a case of CML of 10-year survival].
Topics: Adult; Anemia, Aplastic; Blast Crisis; Bone Marrow; Busulfan; Humans; Leukemia, Myelogenous, Chronic | 1989 |
Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Cystitis; Hemorrhage; Hepatic Veno-Occlusiv | 1987 |
Retinal microaneurysms in a patient with drug-induced aplastic anemia.
Topics: Anemia, Aplastic; Aneurysm; Busulfan; Female; Fluorescein Angiography; Humans; Middle Aged; Ophthalm | 1987 |
Thrombocythaemia. Familial occurrence and transition into blastic crisis.
Topics: Alkaline Phosphatase; Anemia, Aplastic; Blood Coagulation Tests; Bone Marrow Examination; Busulfan; | 1974 |
Haemopoietic precursor cells in experimental hypoplastic marrow failure.
Topics: Anemia, Aplastic; Animals; Bone Marrow; Busulfan; Cell Count; Disease Models, Animal; Female; Granul | 1974 |
Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia.
Topics: Anemia, Aplastic; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Chimera; Diseas | 1974 |
Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran.
Topics: Anemia, Aplastic; Animals; Antibody Formation; Antilymphocyte Serum; Bacteriophages; Blood Cell Coun | 1974 |
Treatment of aplastic anaemia with methenolone.
Topics: Adult; Aged; Anemia, Aplastic; Bone Marrow Examination; Busulfan; Child, Preschool; Cholestasis; Fem | 1972 |
[Acute hemopericardium due to acute thrombocytopenia developing during Busulphan treatment of polycythemia vera].
Topics: Acute Disease; Adult; Anemia, Aplastic; Busulfan; Cardiac Tamponade; Humans; Male; Pericardial Effus | 1973 |
An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan.
Topics: Anemia, Aplastic; Animals; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Busulfan; Disease Model | 1974 |
[Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan].
Topics: Adult; Aged; Anemia, Aplastic; Antineoplastic Agents; Busulfan; Female; Humans; Leukemia, Myeloid; L | 1970 |
Granulopoiesis during myleran-induced suppression of transplantable hen atopoietic stem cells.
Topics: Anemia, Aplastic; Animals; Blood Cell Count; Busulfan; Cell Differentiation; Erythropoiesis; Erythro | 1972 |
Homogeneity of erythropoietin in its effect on self-replication and differentiation of erythropoietin-responsive cells.
Topics: Anemia; Anemia, Aplastic; Animals; Blood; Blood Cells; Busulfan; Cell Differentiation; Cell Division | 1972 |
[Treatment of polycythemia vera].
Topics: Anemia, Aplastic; Busulfan; Humans; Leukopenia; Male; Middle Aged; Polycythemia Vera; Thrombocytopen | 1971 |
[Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
Topics: Adult; Aged; Anemia, Aplastic; Busulfan; Female; Humans; Leukemia, Myeloid; Male; Middle Aged | 1968 |
[The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis].
Topics: Adult; Anemia, Aplastic; Busulfan; Drug Hypersensitivity; Female; Humans; Leukemia, Myeloid; Male | 1967 |
[Megakaryoblastic myelosis].
Topics: Aged; Anemia, Aplastic; Antineoplastic Agents; Blood Transfusion; Bone Marrow Examination; Busulfan; | 1970 |
[Aplastic syndrome in myleran overdose].
Topics: Adrenal Cortex Hormones; Anemia, Aplastic; Anti-Bacterial Agents; Anticoagulants; Blood Transfusion; | 1971 |
[Primary hemorrhagic thrombocythemia. 3 cases].
Topics: Aged; Anemia, Aplastic; Bone Marrow Examination; Busulfan; Female; Humans; Leukemia, Myeloid; Male; | 1971 |
[Is Myleran (busulfan) a leukemogenic substance?].
Topics: Anemia, Aplastic; Animals; Bone Marrow Diseases; Busulfan; Leukemia, Experimental; Rats | 1965 |